A systematic review with meta-analysis published in 2026 gathered 13 studies and 258 neonates with septic arthritis. The estimated proportion of favorable outcomes, defined as normal or near-normal joint function, was 69.7% (95% CI 60.5–77.7). [1]
This data quantifies a significant risk of sequelae and makes follow-up after the acute phase particularly important.
The hip requires particular attention
In the meta-analysis, better outcomes were associated with joints other than the hip. [1]
This is consistent with the literature on pediatric septic hip, where osteonecrosis, cartilage damage, stiffness, and growth alterations can emerge even long after the initial event. [2]
Therefore, when the hip is involved, monitoring should not end with the normalization of inflammatory markers or the resolution of pain.
Data on Timing
Tang and colleagues report a better prognosis in children treated within 7 days. [1]
This threshold cannot be interpreted as a protocol. The aggregated studies do not allow distinguishing the weight of time to diagnosis, initiation of antibiotics, drainage when indicated, and initial severity of the case.
However, the association is consistent with the need to reduce avoidable delays. The PIDS/IDSA recommendations on pediatric bacterial arthritis emphasize rapid diagnosis and therapy and an early decision on source control. [3]
Follow-up After the Acute Phase
Initial clinical improvement does not rule out subsequent sequelae. In follow-up, I consider function, range of motion, symmetry, and growth; after septic arthritis of the hip, assessment of joint structure is particularly important. [1][2]
The duration of follow-up should be adapted to the location, initial severity, and age of the child. In neonates, the substantial growth still to come makes it possible for late-onset alterations to appear that were not evident at the time of discharge.
Limitations of the Meta-analysis
The included case series are small and heterogeneous and come from different periods and healthcare systems. Definitions of outcomes, timing, and treatment strategies are not uniform. [1]
Therefore, 69.7% is not an individual prediction. It is a useful estimate to remember that neonatal septic arthritis can leave sequelae in a non-negligible proportion of patients and requires a pathway that continues beyond the control of the acute infection.
Disclaimer
Informational content; does not replace individual clinical evaluations.
References
[1] Tang Q, Miao X, Ren X, Zhao K, Hu J. Prognostic outcomes of neonatal septic arthritis: a systematic review and meta-analysis. J Orthop Surg Res. 2026. DOI: 10.1186/s13018-026-06662-1. PubMed: https://pubmed.ncbi.nlm.nih.gov/41549270/
[2] Nannini A, et al. Septic arthritis in the pediatric hip joint: systematic review. Front Pediatr. 2023. https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2023.1311862/full
[3] PIDS/IDSA. Acute Bacterial Arthritis in Pediatrics – Clinical Practice Guideline. https://www.idsociety.org/practice-guideline/acute-bacterial-arthritis-in-pediatrics2/
